Search Results 721-730 of 17061 for egfr

  1. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

    Patients with known EGFR-activating mutations or ALK rearrangements should have received treatment with a targeted kinase inhibitor (e.g., erlotinib ...

  2. Rectal Cancer Clinical Trials - Mayo Clinic Research

    ... EGFR antibody therapy) that are used in routine clinical practice. Currently, the only way to know if your tumor has one of these mutations is to take a ...

  3. End-stage renal disease - Doctors and departments - Mayo Clinic

    When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

  4. Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study - Mayo Clinic

    ... EGFR, ALK, ROS1, BRAF, RET, NTRK, KRAS, HER2 and MET sensitizing mutations), must have previously received at least one of the approved therapy(s). Prior ...

  5. Registry for Mayo Clinic Adult Congenital Heart Disease Control Population

    eGFR < 30. Current orthopedic limitations. Eligibility last updated 2/22/22. Questions regarding updates should be directed to the study team contact ...

  6. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients - Mayo Clinic

    Received or are not eligible for standard of care fluoropyrimidine(s), oxaliplatin, irinotecan, anti-VEGF and EGFR-targeted therapies. ii. Non ...

  7. Focal segmental glomerulosclerosis (FSGS) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  8. End-stage renal disease - Doctors and departments - Mayo Clinic

    When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

  9. An Adjuvant Study To Evaluate SMS001 (Paclitaxel) In Non-Small Cell Lung Cancer - Mayo Clinic

    eGFR \>60mL/min/1.73m² 7. QT interval corrected for heart rate using Frederica's formula (QTcF): males \< 450msec and females \< 470msec 8. Operating ...

  10. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary effectiveness of KIN-3248, an oral small molecule FGFR ...